The FDA and CDC, in collaboration with state and local partners, are investigating illnesses in a multistate outbreak of Salmonella Newport infections linked to Rosabella-brand moringa powder capsules distributed by Ambrosia Brands LLC.
Based on epidemiological information collected by CDC, a total of seven people infected with the outbreak strain of Salmonella have been reported from seven states. Illnesses started on dates ranging from November 7, 2025, to January 8, 2026. Of the three people interviewed, three (100%) reported eating Rosabella-brand moringa powder capsules. There have been three hospitalizations, and no deaths have been reported. The Salmonella strain associated with this outbreak is resistant to all first-line and alternative antibiotics commonly recommended for the treatment of Salmonella infections. For healthcare providers, learn more about this strain’s resistance and get guidance for diagnosing and treating infections.
FDA has recommended that Ambrosia Brands LLC recall all Rosabella-brand moringa powder capsules from the market and the firm has agreed to conduct a recall of certain lots. Please see the table below for a complete list of lot codes and expirations dates of potentially contaminated product.
Consumers and retailers who purchased these lots of Rosabella-brand moringa powder capsules should not eat, sell or further distribute this product and should throw it away or return it to the place of purchase.
FDA is conducting a traceback investigation to determine a source of contamination and is working with state partners to collect samples. As additional products may be contaminated, this advisory will be updated as more information becomes available.
Link to Case Count Map Provided by CDC Case Count Map Provided by CDC
